A mRNA Vaccine Encoding for a 60-mer G Glycoprotein Nanoparticle Elicits a Robust Neutralizing Antibodies Response Against the Nipah Virus DOI Creative Commons

Pascal Brandys,

César G. Albariño,

Shilpi Jain

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Авг. 5, 2024

The Nipah virus is a zoonotic pathogen causing encephalitis and acute respiratory illness in humans with very high fatality rates. Here we report novel messenger RNA vaccine that directly encodes for nanoparticle displaying 60 head domains of the G (NiV G) glycoprotein acts as highly effective antigen. A encoding NiV elicits antibody titers against robust neutralizing response pseudotyped system. We ultimately find proposed mRNA (mRNA G-NP) provides flexible platform development vaccines will likely be great value combatting future outbreaks.

Язык: Английский

Clonal Interference and Changing Selective Pressures Shape the Escape of Sars-Cov-2 from Hundreds of Antibodies DOI
Hugh K. Haddox,

O. Aziz,

Jared Galloway

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations DOI Creative Commons
Arjun K. Aditham,

Caelan E. Radford,

Caleb R. Carr

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Дек. 17, 2024

Abstract Rabies virus causes nearly 60,000 human deaths annually. Antibodies that target the rabies glycoprotein (G) are being developed as post-exposure prophylactics, but mutations in G can render such antibodies ineffective. Here, we use pseudovirus deep mutational scanning to measure how all single amino-acid affect cell entry and neutralization by a panel of antibodies. These measurements identify sites critical for G’s function, define constrained regions attractive epitopes clinical antibodies, including at apex base protein. We provide complete maps escape eight monoclonal some or development. Escape most present natural strains. Overall, this work provides comprehensive information on functional antigenic effects help inform development stabilized vaccine antigens resilient genetic variation.

Язык: Английский

Процитировано

1

A mRNA Vaccine Encoding for a 60-mer G Glycoprotein Nanoparticle Elicits a Robust Neutralizing Antibodies Response Against the Nipah Virus DOI Creative Commons

Pascal Brandys,

César G. Albariño,

Shilpi Jain

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Авг. 5, 2024

The Nipah virus is a zoonotic pathogen causing encephalitis and acute respiratory illness in humans with very high fatality rates. Here we report novel messenger RNA vaccine that directly encodes for nanoparticle displaying 60 head domains of the G (NiV G) glycoprotein acts as highly effective antigen. A encoding NiV elicits antibody titers against robust neutralizing response pseudotyped system. We ultimately find proposed mRNA (mRNA G-NP) provides flexible platform development vaccines will likely be great value combatting future outbreaks.

Язык: Английский

Процитировано

0